Clopidogrel induced urticarial rash in a patient with left main stem percutaneous coronary intervention: management issues.
case_report · Level V
Where this comes from
- Record sourced from PubMed, PMID 14966075.
- Also identified by PMC identifier 1768116.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Clopidogrel, an ideal treatment for prevention of subacute stent thrombosis, may not be feasible to use in every patient. Ticlopidine (plus aspirin) is a very good alternative, although the risks of life threatening neutropenia should mandate regular monitoring of blood counts. It is proposed that patients undergoing angioplasty and stenting should carry a warning card in an effort to make the public and general practitioners aware that antiplatelet treatment after angioplasty plays an important part in ensuring successful outcome.
Medical subject headings
- Drug Eruptions
- Platelet Aggregation Inhibitors
- Stents
- Ticlopidine
- Urticaria